Frost & Sullivan

AUGUST 29, 2024

However, the pharma/biopharma industry overall shows stagnant R&D activity. Conversely, small-to-mid, and emerging biopharma players, with 1 or 2 molecules in the pipeline, contribute over 16%. As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8%

Biopharma 52

Biopharma Biotechnology Contract research organization Utilities 52

Frost & Sullivan

MARCH 22, 2024

However, the pharma/biopharma industry shows overall stagnant R&D activity. Small-to-mid and emerging biopharma players contribute over 16%. As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% increase from 2022. billion, with a modest 2.5%

Ecosystems 52

Ecosystems Biopharma Biotech Contract research organization 52

Jake Jorgovan

NOVEMBER 27, 2023

Biopharmaceutical Consulting: Supporting every aspect of the biopharma value chain, including R&D, operations, manufacturing, commercialization, and mergers and acquisitions (M&A). Healthcare Automation: Utilizing AI and robotic process automation to streamline tasks, reduce costs, and address talent shortages.

Life science 130

Life science Biopharmaceuticals Biotech Mergers and acquisition activities 130

Frost & Sullivan

AUGUST 23, 2023

The combination of claims and EHR data, an expanding incorporation of genomic insights, and a continued emphasis on RWE and diversity, make Optum the partner of choice for biopharmaceutical (biopharma) companies seeking to create higher-value treatments while accelerating their time to market.

Life science 52

Life science Biopharmaceuticals Biopharma Partnering capability and readiness 52

Planview Blog

MAY 18, 2023

Planview can be utilized at every level, and there is a use case for it in every organization. Find out how this long-standing biopharma company uses Planview Advisor’s advanced analytics capabilities to uncover R&D value. However, this is not entirely accurate.

Biopharma 52

Biopharma Life science Biotech Utilities 52

Jake Jorgovan

FEBRUARY 5, 2025

JGB Biopharma Consulting, Inc. JGB Biopharma Consulting, Inc. With over a decade of experience, JGB Biopharma has been instrumental in connecting companies with qualified talent across a spectrum of industries including biopharmaceuticals, medical devices, diagnostics, bioinformatics, and medical/high-tech blends.

Biotechnology 130

Biotechnology Life science Biotech Biopharma 130